The report covers forecast and analysis for the blood glucose monitoring system market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the blood glucose monitoring system market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the blood glucose monitoring system market on a global level.
In order to give the users of this report a comprehensive view of the blood glucose monitoring system market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type and regional expansion of major participants involved in the market.
The study provides a decisive view of the blood glucose monitoring system market by segmenting it based on product type, testing site, indications, end-user, and region. All the segments have been analyzed based on present and future trends and the market is forecasted from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and The Middle East & Africa. This segmentation includes demand for blood glucose monitoring system market based on all segments in all the regions and countries.
The key players in the global blood glucose monitoring system market are Abbott Laboratories, Novo Nordisk, Hoffmann-La Roche Ltd., Sanofi, Medtronic, Nova Biomedical, B. Braun Melsungen, Terumo Corporation, ARKRAY Inc., and Becton Dickinson.
This report segments the global blood glucose monitoring system market as follows:
Global Blood Glucose Monitoring System Market: Product Segment Analysis
- Self-Monitoring
- Blood Glucose Meters
- Testing Strips
- Lancets & Lancing Devices
- Continuous Glucose Monitoring Devices
Global Blood Glucose Monitoring System Market: Testing Site Segment Analysis
- Fingertip Testing
- Alternate Site Testing
Global Blood Glucose Monitoring System Market: Indication Segment Analysis
- Type-I Diabetes
- Adult
- Pediatrics
- Type-II Diabetes
- Adult
- Pediatrics
- Gestational Diabetes
Global Blood Glucose Monitoring System Market: End-User Segment Analysis
- Hospitals
- Clinics
- Homecare
Global Blood Glucose Monitoring System Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
